Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Digestion ; 72(4): 248-53, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16319461

RESUMO

BACKGROUND/AIMS: The majority of Crohn's disease patients undergo surgery. However, the factors that predict post-operative recurrence remain controversial. The aim of the present study was to shed light on the potential predictors of such recurrence. METHODS: 86 patients who underwent operative procedures for Crohn's disease were retrospectively studied. Recurrence was defined as the need for a second operation. Life table and multivariate analysis were performed to find the predictors of recurrence. RESULTS: In 26/86 (30%) of the patients, post-operative recurrence was diagnosed within a mean of 42 months of the follow-up. Logistic regression analysis revealed that smoking (OR 3.69, 95% CI 2.06-11.52) and perforating disease (OR 4.09, 95% CI 1.31-12.65) were associated with a risk of recurrence. However, survival analysis showed that only perforating disease was associated with an early post-operative recurrence (log-rank test, p < 0.001). Neither resected surgical specimen characteristics, nor the duration and the location of the disease were found to predict the need for a second operation. CONCLUSION: The risk for Crohn's disease patients who undergo surgery is related to the presence of perforating disease and smoking, which predict the need for a second operation. The former is associated with an even earlier recurrence.


Assuntos
Doença de Crohn/cirurgia , Procedimentos Cirúrgicos do Sistema Digestório , Encaminhamento e Consulta , Adulto , Feminino , Seguimentos , Humanos , Masculino , Período Pós-Operatório , Prognóstico , Recidiva , Análise de Regressão , Reoperação , Estudos Retrospectivos , Fatores de Risco , Fumar/efeitos adversos
2.
Endoscopy ; 36(6): 504-7, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15202046

RESUMO

BACKGROUND AND STUDY AIMS: Outcomes following early colonoscopy in patients with acute diverticulitis have not previously been studied. The present study describes the effects of early colonoscopy in patients with acute diverticulitis. PATIENTS AND METHODS: Consecutive patients hospitalized for acute diverticulitis were included in the study. In the first phase, patients with adjacent peridiverticular air or fluid on computed tomography (CT) were excluded. In the second phase of the study, only patients with free intraperitoneal air were excluded. RESULTS: The study population consisted of 107 patients. During the first phase of the study, 49 patients were included; 10 were excluded because of peridiverticular air or fluid. The remaining 39 patients underwent uneventful colonoscopy. During the second phase of the study, 58 patients were included; four were excluded because of free air in the peritoneum. The remaining 54 patients underwent colonoscopy, and perforation of the sigmoid colon occurred in one patient with peridiverticular air. Complete colonoscopy to the cecum or to the obstructing tumor was achieved in 76 patients (81.7 %). A second colonoscopy performed 6 weeks later in 16 of the remaining 17 patients was successfully completed. Findings during the first colonoscopy were polyps in nine cases, polyp with infiltrating adenocarcinoma in one, obstructing adenocarcinoma in one, and a bone trapped in a diverticulum in another one. The latter two patients had a more protracted course and were clearly the ones who benefited most from the colonoscopy. CONCLUSIONS: Early colonoscopy in patients with acute diverticulitis may alter the working diagnosis and be of therapeutic value. The rate of cecal intubation is lower and the perforation rate appears to be higher. A clear-cut indication therefore has to be evident clinically.


Assuntos
Colonoscopia , Doença Diverticular do Colo/diagnóstico , Adenocarcinoma/diagnóstico , Adulto , Idoso , Idoso de 80 Anos ou mais , Ar , Ceco/patologia , Colo Sigmoide/lesões , Neoplasias do Colo/diagnóstico , Pólipos do Colo/diagnóstico , Doença Diverticular do Colo/diagnóstico por imagem , Exsudatos e Transudatos , Feminino , Seguimentos , Corpos Estranhos/diagnóstico , Humanos , Obstrução Intestinal/diagnóstico , Masculino , Pessoa de Meia-Idade , Cavidade Peritoneal , Projetos Piloto , Estudos Prospectivos , Tomografia Computadorizada por Raios X
3.
Endoscopy ; 36(6): 522-6, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15202049

RESUMO

BACKGROUND AND STUDY AIMS: Percutaneous endoscopic gastrostomy (PEG) is a method used for feeding patients who are unable to eat. High early mortality rates among hospitalized patients have been reported. The aim of this study was to shed light on the risk factors for early mortality after PEG tube insertion. PATIENTS AND METHODS: Outpatients from nursing homes and hospitalized patients who underwent PEG between July 1995 and July 2001 were compared. Survival analysis was used to assess mortality after PEG. In a logistic regression analysis, mortality within 30 days among hospitalized patients was chosen as the outcome variable and the predictor variables were demographic characteristics, co-morbid conditions, and indication for PEG. RESULTS: A total of 502 PEG tubes were inserted in 419 hospitalized and 83 nursing-home patients. The prevalence of co-morbid conditions was similar in the two groups. Both the 30- and 60-day mortality rates were around six times higher in the hospitalized patient group than in the nursing-home patient group (30-day mortality rate 8 % vs. 1.2 %, P = 0.034; 60-day mortality rate 12 % vs. 2.4 %, P = 0.016). Risk factors for 30-day mortality among hospitalized patients were: serum albumin < 3 g/dl (odds ratio 2.82, 95 % CI 1.34 - 5.96), chronic obstructive pulmonary disease (odds ratio 2.79, 95 % CI 1.26 - 6.14), and diabetes mellitus (odds ratio 2.44, 95 % CI 1.20 - 4.97). CONCLUSIONS: Compared with nursing-home patients, hospitalized patients are at higher risk for early mortality after PEG. The presence of diabetes, chronic obstructive pulmonary disease, and a low serum albumin level each increase the 30-day mortality risk among hospitalized patients threefold.


Assuntos
Gastroscopia/mortalidade , Gastrostomia/mortalidade , Idoso , Idoso de 80 Anos ou mais , Diabetes Mellitus/epidemiologia , Nutrição Enteral/mortalidade , Feminino , Seguimentos , Hospitalização/estatística & dados numéricos , Humanos , Israel/epidemiologia , Tempo de Internação/estatística & dados numéricos , Modelos Logísticos , Masculino , Casas de Saúde/estatística & dados numéricos , Doença Pulmonar Obstrutiva Crônica/epidemiologia , Fatores de Risco , Albumina Sérica/análise , Análise de Sobrevida
4.
Am J Med Sci ; 323(5): 269-72, 2002 May.
Artigo em Inglês | MEDLINE | ID: mdl-12018671

RESUMO

Soft tissue infection caused by Stenotrophomonas maltophilia is uncommon, but nosocomial infections had been reported. We describe herein 2 young female patients, with severe neutropenia, on broad spectrum antimicrobial agents for neutropenic fever, with Hickman-type central venous catheter, who developed mucocutaneous and soft tissue infections with rapidly progressive and devastating course. Cultures from the skin of both patients and from blood of one of them grew S. maltophilia. Both patients died and post mortem examination of the patient with S. maltophilia bacteremia revealed extensive soft tissue necrosis and a vegetation on the mitral valve that grew S. maltophilia. The infection occurred in both patients at the same time and in the same ward. Epidemiological study was done, and surveillance cultures grew the organism from the faucets from the room of 1 patient and also from some of the neighboring rooms in our ward but not from any other ward nor in the water reservoir of the building.


Assuntos
Infecção Hospitalar/transmissão , Reservatórios de Doenças , Infecções por Bactérias Gram-Negativas/transmissão , Hospedeiro Imunocomprometido , Dermatopatias Bacterianas/transmissão , Infecções dos Tecidos Moles/transmissão , Stenotrophomonas maltophilia , Abastecimento de Água , Adulto , Infecção Hospitalar/imunologia , Infecção Hospitalar/microbiologia , Evolução Fatal , Feminino , Infecções por Bactérias Gram-Negativas/microbiologia , Humanos , Neutropenia/complicações , Dermatopatias Bacterianas/microbiologia , Infecções dos Tecidos Moles/microbiologia
5.
Biochem Biophys Res Commun ; 273(2): 417-20, 2000 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-10873620

RESUMO

Angiotensin II (Ang II) and oxidized LDL (Ox-LDL) are risk factors for atherosclerosis, and both of them contribute to macrophage cholesterol accumulation, the hallmark of early atherosclerosis. As Ang II was shown to increase macrophage uptake of Ox-LDL, we investigated the effect of losartan, an Ang II receptor antagonist with antiatherogenic properties, on the cellular uptake of Ox-LDL by human monocyte-derived macrophages (HMDM) from hypercholesterolemic patients. Eight normotensive hypercholesterolemic patients were treated with losartan (50 mg/day) for a period of 4 weeks. Losartan therapy did not significantly affect the degradation of native LDL by the patients' HMDM. However, losartan therapy significantly reduced HMDM uptake of Ox-LDL as shown by a 78% reduction in Ox-LDL cell-association and a 21% reduction in Ox-LDL degradation. CD36 (an Ox-LDL receptor) mRNA expression in HMDM obtained after losartan treatment was decreased by 54% compared to HMDM obtained before treatment. The ability of losartan to inhibit HMDM CD36 mRNA expression and, hence, Ox-LDL uptake and macrophage foam cell formation is probably related to the blockage of Ang II binding to the cell surface and thus to the prevention of Ang II atherogenic effects.


Assuntos
Hipercolesterolemia/tratamento farmacológico , Hipercolesterolemia/metabolismo , Lipoproteínas LDL/metabolismo , Losartan/farmacologia , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Angiotensina II/biossíntese , Antagonistas de Receptores de Angiotensina , Arteriosclerose/etiologia , Arteriosclerose/metabolismo , Arteriosclerose/prevenção & controle , Transporte Biológico Ativo/efeitos dos fármacos , Antígenos CD36/genética , Expressão Gênica/efeitos dos fármacos , Humanos , Hipercolesterolemia/genética , Técnicas In Vitro , Oxirredução , RNA Mensageiro/genética , RNA Mensageiro/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...